These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 27931266)
21. An examination of factors affecting persistence with initial antipsychotic treatment in patients with schizophrenia. Tunis SL; Faries DE; Stensland MD; Hay DP; Kinon BJ Curr Med Res Opin; 2007 Jan; 23(1):97-104. PubMed ID: 17257471 [TBL] [Abstract][Full Text] [Related]
22. [Adherence to antipsychotic medication in schizophrenia patients]. Baloush-Kleinman V; Poyurovsky M; Koren D; Schneidman M; Weizman A; Shnitt D Harefuah; 2002 Dec; 141(12):1042-9, 1090. PubMed ID: 12534202 [TBL] [Abstract][Full Text] [Related]
23. Postoperative hypertension: a multicenter, prospective, randomized comparison between intravenous nicardipine and sodium nitroprusside. Halpern NA; Goldberg M; Neely C; Sladen RN; Goldberg JS; Floyd J; Gabrielson G; Greenstein RJ Crit Care Med; 1992 Dec; 20(12):1637-43. PubMed ID: 1458938 [TBL] [Abstract][Full Text] [Related]
24. Effects of typical, atypical, and no antipsychotic drugs on visual contrast detection in schizophrenia. Chen Y; Levy DL; Sheremata S; Nakayama K; Matthysse S; Holzman PS Am J Psychiatry; 2003 Oct; 160(10):1795-801. PubMed ID: 14514493 [TBL] [Abstract][Full Text] [Related]
25. The impact of antipsychotic side effects on attitudes towards medication in people with schizophrenia and related disorders. Chiang YL; Klainin-Yobas P; Ignacio J; Chng CM J Clin Nurs; 2011 Aug; 20(15-16):2172-82. PubMed ID: 21539628 [TBL] [Abstract][Full Text] [Related]
27. DNA methylation and antipsychotic treatment mechanisms in schizophrenia: Progress and future directions. Ovenden ES; McGregor NW; Emsley RA; Warnich L Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():38-49. PubMed ID: 29017764 [TBL] [Abstract][Full Text] [Related]
28. [Methodological approaches to assessment of negative symptoms during pharmacotherapy of schizophrenia]. Tsygankov BD; Ovsiannikov SA; Khannanova AN Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(11):101-6. PubMed ID: 20120071 [No Abstract] [Full Text] [Related]
29. Factors related to different reasons for antipsychotic drug discontinuation in the treatment of schizophrenia: a naturalistic 18-month follow-up study. Vita A; Barlati S; Deste G; Corsini P; De Peri L; Sacchetti E Psychiatry Res; 2012 Dec; 200(2-3):96-101. PubMed ID: 22858250 [TBL] [Abstract][Full Text] [Related]
30. [Pharmacotherapy in schizophrenia--comparison of second generation antipsychotic agents]. Melamed Y; Finkel B; Barak Y; Zipris P; Oyffe I; Weizman A; Bleich A Harefuah; 2005 Apr; 144(4):285-90, 301. PubMed ID: 15889614 [TBL] [Abstract][Full Text] [Related]
31. Examining the Use of Sodium Nitroprusside in Coronary Artery Bypass Grafting: Is the Benefit Worth the Cost? Gibson CM; Davis S; Bradford D Hosp Pharm; 2017 Jul; 52(7):502-507. PubMed ID: 29276280 [No Abstract] [Full Text] [Related]
32. Pulmonary vasodilation after heart transplantation. A comparison among prostacyclin, sodium nitroprusside, and nitroglycerin on right ventricular function and pulmonary selectivity. Kieler-Jensen N; Milocco I; Ricksten SE J Heart Lung Transplant; 1993; 12(2):179-84. PubMed ID: 8476888 [TBL] [Abstract][Full Text] [Related]
33. Safety and efficacy of sodium nitroprusside during prolonged infusion in pediatric patients. Hammer GB; Lewandowski A; Drover DR; Rosen DA; Cohane C; Anand R; Mitchell J; Reece T; Schulman SR Pediatr Crit Care Med; 2015 Jun; 16(5):397-403. PubMed ID: 25715047 [TBL] [Abstract][Full Text] [Related]
34. World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia. Tandon R; Belmaker RH; Gattaz WF; Lopez-Ibor JJ; Okasha A; Singh B; Stein DJ; Olie JP; Fleischhacker WW; Moeller HJ; Schizophr Res; 2008 Mar; 100(1-3):20-38. PubMed ID: 18243663 [TBL] [Abstract][Full Text] [Related]
35. Schizophrenia: attitudes of patients and professional carers towards the illness and antipsychotic medication. Rettenbacher MA; Burns T; Kemmler G; Fleischhacker WW Pharmacopsychiatry; 2004 May; 37(3):103-9. PubMed ID: 15138893 [TBL] [Abstract][Full Text] [Related]
36. Do antipsychotic medications reduce or increase mortality in schizophrenia? A critical appraisal of the FIN-11 study. De Hert M; Correll CU; Cohen D Schizophr Res; 2010 Mar; 117(1):68-74. PubMed ID: 20060684 [TBL] [Abstract][Full Text] [Related]
37. Influence of methylene blue and oxyhemoglobin on mammalian vascular responses to sodium nitroprusside and nitroglycerin. Inoue M; Okamura T; Toda N Arch Int Pharmacodyn Ther; 1991; 311():104-21. PubMed ID: 1789709 [TBL] [Abstract][Full Text] [Related]
38. Can antipsychotic treatment contribute to drug addiction in schizophrenia? Samaha AN Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jul; 52():9-16. PubMed ID: 23793001 [TBL] [Abstract][Full Text] [Related]